Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-06-14
1997-11-18
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544267, C07D47306, A61K 3152
Patent
active
056888023
ABSTRACT:
The invention relates to new xanthine derivatives of general formula I, processes for preparing them and their use as pharmaceutical compositions.
REFERENCES:
patent: 5175291 (1992-12-01), Kufner-Muhl
patent: 5447933 (1995-09-01), Suzuki et al.
patent: 5525607 (1996-06-01), Suzuki et al.
Ensinger Helmut
Kufner-Muhl Ulrike
Kuhn Franz Josef
Lehr Erich
Schingnitz Gunter
Boehringer Ingelheim KG
Raymond Robert P.
Rieder Wendy E.
Shah Mukund J.
Sripada Pavanaram K.
LandOfFree
Bornyl xanthine derivatives with adenosine-antagonistic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bornyl xanthine derivatives with adenosine-antagonistic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bornyl xanthine derivatives with adenosine-antagonistic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1565884